Understanding Growth Trends in Korea Continuous Glucose Monitoring Devices Market Market

Key Insights

The Korea Continuous Glucose Monitoring (CGM) Devices market, valued at $84.24 million in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, increasing awareness of advanced diabetes management, and government initiatives promoting healthcare technology adoption in South Korea. The 9.40% Compound Annual Growth Rate (CAGR) from 2025 to 2033 indicates significant market expansion. Key market segments include components like sensors and durables (receivers and transmitters), and geographically, Seoul, Busan, and other major metropolitan areas are expected to contribute significantly to market growth due to higher concentrations of population and healthcare infrastructure. The increasing adoption of technologically advanced CGM systems featuring improved accuracy, smaller form factors, and enhanced integration with mobile apps will further fuel market expansion. Competition among major players like Dexcom, Eversense, Medtronic, Abbott, and Ascensia will likely intensify, leading to innovation in product features and pricing strategies. While challenges such as high initial device costs and potential reimbursement hurdles may present some constraints, the long-term benefits of improved diabetes management and better patient outcomes are expected to outweigh these limitations, supporting sustained market growth.

The market's growth trajectory is heavily influenced by factors such as technological advancements leading to more user-friendly and accurate devices, growing government support for diabetes care, and an increasing focus on preventative healthcare. The increasing geriatric population in Korea further contributes to the market's potential, as this demographic is particularly susceptible to diabetes. Regional variations in market penetration are expected, with metropolitan areas exhibiting higher adoption rates due to better access to healthcare facilities and higher disposable incomes. The market segmentation by component reveals the significance of durable components alongside the consumables (sensors), highlighting the recurring revenue streams for market players. Future growth opportunities lie in developing integrated solutions that seamlessly connect CGM data with insulin delivery systems, enhancing the overall efficacy of diabetes management.

Korea Continuous Glucose Monitoring Devices Market Report: 2019-2033

This comprehensive report provides a detailed analysis of the Korea Continuous Glucose Monitoring (CGM) Devices market, offering invaluable insights for stakeholders seeking to understand market dynamics, growth opportunities, and competitive landscapes. The study period covers 2019-2033, with 2025 as the base and estimated year. The report projects market trends from 2025-2033, using historical data from 2019-2024. The market is segmented by provinces (Seoul, Busan, Daegu Metropolitan City, Incheon Metropolitan City, Gwangju, and Other Provinces) and components (Sensors and Durables – Receivers and Transmitters). Key players include Dexcom Inc, Eversense, Medtronic PLC, Abbott Diabetes Care Inc, and Ascensia. The report projects a market value of xx Million by 2033.

Korea Continuous Glucose Monitoring Devices Market Composition & Trends

The Korean CGM devices market is characterized by moderate concentration, with key players holding significant market share. The market share distribution in 2025 is estimated as follows: Abbott Diabetes Care Inc (xx%), Medtronic PLC (xx%), Dexcom Inc (xx%), Eversense (xx%), Ascensia (xx%), and Others (xx%). Innovation is driven by advancements in sensor technology, miniaturization, improved accuracy, and integration with insulin delivery systems. The regulatory landscape is relatively favorable, encouraging market growth. Substitute products, such as self-monitoring blood glucose (SMBG) systems, still hold a significant presence, but CGM's superior convenience and data-driven insights are driving a steady shift. End-users primarily comprise patients with diabetes, with increasing adoption among both type 1 and type 2 diabetes patients. The market has witnessed significant M&A activity, exemplified by Medtronic PLC's acquisition of EOFlow Co. Ltd in 2023, signaling a trend of consolidation and expansion within the industry. The total value of M&A deals in the historical period (2019-2024) is estimated at xx Million.

• Market Concentration: Moderate, with key players holding significant shares.
• Innovation Catalysts: Sensor technology advancements, miniaturization, improved accuracy.
• Regulatory Landscape: Favorable, supporting market growth.
• Substitute Products: SMBG systems, but CGM adoption is increasing.
• End-User Profile: Patients with diabetes (Type 1 & Type 2).
• M&A Activity: Significant, with deals valued at xx Million in 2019-2024.

Korea Continuous Glucose Monitoring Devices Market Industry Evolution

The Korean CGM devices market has exhibited a steady growth trajectory over the historical period (2019-2024), with a CAGR of xx%. This growth is primarily fueled by rising diabetes prevalence, increased awareness of CGM benefits, and technological advancements leading to more accurate, user-friendly devices. Technological innovations, such as improved sensor accuracy, longer sensor lifespan, and seamless integration with mobile applications, have significantly enhanced patient experience and treatment outcomes. Consumer demand is shifting towards smaller, less invasive, and more integrated devices that provide comprehensive data insights and facilitate better diabetes management. The market is expected to maintain a robust growth rate during the forecast period (2025-2033), driven by continued technological advancements, supportive government policies, and increasing healthcare expenditure. Factors such as pricing pressures and competition remain potential challenges. The adoption rate of CGM devices is projected to increase from xx% in 2024 to xx% in 2033. The market is anticipated to reach xx Million by 2033.

Leading Regions, Countries, or Segments in Korea Continuous Glucose Monitoring Devices Market

Seoul, as the most populous and economically advanced province, dominates the Korean CGM devices market. Its well-developed healthcare infrastructure and higher disposable incomes contribute significantly to higher adoption rates. Other major cities such as Busan, Daegu, and Incheon also show substantial market presence, though at a lower scale compared to Seoul. The Sensors segment currently holds a larger market share than the Durables (Receivers and Transmitters) segment due to the higher frequency of sensor replacements compared to the replacement cycle of receivers and transmitters.

• Key Drivers for Seoul's Dominance:

  • High diabetes prevalence and awareness.
  • Advanced healthcare infrastructure and access to technology.
  • Higher disposable incomes and healthcare expenditure.
  • Strong presence of major healthcare providers.

• Key Drivers for Sensor Segment Dominance:

  • Higher frequency of sensor replacements.
  • Continuous technological advancements in sensor technology improving accuracy and longevity.
  • Increased demand driven by growing CGM adoption.

Korea Continuous Glucose Monitoring Devices Market Product Innovations

Recent innovations in CGM devices focus on improving accuracy, minimizing invasiveness, extending sensor lifespan, and enhancing data integration. New devices feature smaller sensor sizes, improved calibration algorithms, and advanced features such as real-time glucose data transmission to smartphones and integration with insulin pumps. These advancements aim to enhance patient comfort, improve treatment outcomes, and simplify diabetes management. The emphasis on user-friendly interfaces and mobile applications has broadened accessibility and increased adoption rates. Several companies are developing continuous glucose monitors with advanced features like prediction algorithms and integration with wearable fitness trackers.

Propelling Factors for Korea Continuous Glucose Monitoring Devices Market Growth

Several factors contribute to the market's growth: the rising prevalence of diabetes in Korea, the increasing awareness about the benefits of CGM among both patients and healthcare professionals, favorable government policies promoting early diabetes detection and management, and continuous technological advancements leading to smaller, more accurate, and user-friendly devices. The expanding coverage of health insurance for CGM devices further fuels market growth.

Obstacles in the Korea Continuous Glucose Monitoring Devices Market

High device costs can limit accessibility, particularly for patients with limited financial resources. Although health insurance coverage is expanding, out-of-pocket expenses remain a challenge. Competition among established players and the emergence of new entrants can lead to price pressures. Supply chain disruptions, particularly in the sourcing of key components for sensors, can affect market stability. Strict regulatory requirements can delay product launches and increase development costs.

Future Opportunities in Korea Continuous Glucose Monitoring Devices Market

Expansion into underserved regions of Korea, especially rural areas, holds significant potential. The development of integrated systems combining CGM with insulin delivery systems and remote patient monitoring solutions will broaden applications. Growing demand for personalized medicine and tailored diabetes management strategies offers opportunities for CGM device personalization and data analytics services.

Major Players in the Korea Continuous Glucose Monitoring Devices Market Ecosystem

• Dexcom Inc
• Eversense
• Medtronic PLC
• Abbott Diabetes Care Inc
• Ascensia

Key Developments in Korea Continuous Glucose Monitoring Devices Market Industry

• May 2023: Medtronic PLC acquired EOFlow Co. Ltd., expanding its product portfolio and capabilities in the CGM and insulin delivery space. This acquisition is expected to significantly impact the market's competitive landscape.
• Jan 2023: Adela, an online seller of Abbott FreeStyle Libre, announced a 10% price increase due to rising raw material costs and inflation. This event highlights the impact of macroeconomic factors on CGM device pricing and market dynamics.

Strategic Korea Continuous Glucose Monitoring Devices Market Forecast

The Korea CGM devices market is poised for continued growth, driven by technological advancements, increasing diabetes prevalence, and expanding healthcare coverage. Future opportunities lie in personalized medicine, system integration, and expansion into underserved markets. The market is expected to witness significant innovation and consolidation, leading to a more competitive yet dynamic landscape. The continued focus on improving device accuracy, reducing invasiveness, and lowering costs will be crucial for driving broader adoption and achieving significant market expansion.

Korea Continuous Glucose Monitoring Devices Market Segmentation

• 1. Component
  • 1.1. Sensors
  • 1.2. Durables (Receivers and Transmitters)
• 2. Provinces (Quantitative Analysis)
  • 2.1. Seoul
  • 2.2. Busan
  • 2.3. Daegu Metropolitan City
  • 2.4. Incheon Metropolitan City
  • 2.5. Gwangju
  • 2.6. Other Provinces

Korea Continuous Glucose Monitoring Devices Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific